TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam Gregory, Lars Fugger, Calliope A. Dendrou et al.|Nature|2012Cited by 382
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Hal Drakesmith, Zhichao Ai et al.|Cell|2022Cited by 327
Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresourceCalliope A. Dendrou, Linda S. Wicker, Vincent Plagnol et al.|Nature Genetics|2009Cited by 279
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Christopher D. Buckley, Jacqueline H. Y. Siu et al.|Nature Immunology|2024Cited by 83
A blood atlas of COVID-19 defines hallmarks of disease severity and specificityDavid Ahern, Susanna Dunachie, Zhichao Ai et al.|medRxiv|2021Cited by 35